 REDWOOD CITY, Calif.--BUSINESS WIRE--Pulmonx Corporation Nasdaq: LUNG Pulmonx a global leader in minimally invasive treatments for severe lung disease, today announced the company will present at the upcoming Canaccord Genuity 42nd Annual Growth Conference in Boston. Management is scheduled to present on Wednesday, August 10, 2022, at 1:00 PM PT 4:00 PM ET. A live and archived webcast of the presentation will be available on Investors section of the Pulmonx website at 